Journals / Endokrinolojide Yönelişler / 2002 / Cilt: 11 - Sayı: 4

Diabetes mellitus and liver functions

Diabetik hastalarda karaciğer fonksiyon testleri ve ultrasonografik değerlendirmesi

Pages
157–159
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Frequency of hepatosteatosis and hepatomegaly is increased in patients with poorly controlled and long-duration diabetes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to observe abnormal liver function tests, the frequency of hepatomegaly and hepatosteatosis in diabetic patients.
📊
Key Findings & Data:One or more were found to be elevated in 34 (%50) patients.
💡
Conclusion & Impact:Results: Frequency of hepatosteatosis and hepatomegaly is increased in patients with poorly controlled and long-duration diabetes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to observe abnormal liver function tests, the frequency of hepatomegaly and hepatosteatosis in diabetic patients. Methods: Sixty-eight consecutive diabetic patients admitting to outpatient Clinics of Endocrinology and Metabolism division Meram Medical Faculty were evaluated for liver function test abnormalities. Findings: Levels of alanine aminotranspherase, aspartate aminotranspherase, gamma glutamyl transpeptidase and alkaline phosphatase were studied. One or more were found to be elevated in 34 (%50) patients. Of these 34 cases, steatosis was diagnosed in 26 patients (76,4%) , cirrhosis in 1 (2,9%), chronic viral hepatitis in 2 (5,8%). Five patients were HbsAg positive (7,3%) and three were positive for HCV (anti HCV positive) (%4,4). Results: Frequency of hepatosteatosis and hepatomegaly is increased in patients with poorly controlled and long-duration diabetes.

Özet

Amaç: Adult Diabetes Mellituslu hastalarda anormal karaciğer fonksiyon testleri ile hepatomegali ve steatoz sıklığını araştırmayı amaçladık.. Yöntem: Selçuk Üniversitesi Meram Tıp Fakültesi Endokrinoloji polikliniğine başvuran ardışık 68 Diabetes Mellituslu hasta değerlendirmeye alındı. Bulgular: 34 hastada (%50) alanin aminotransferaz, aspartat aminotransferaz, gamaglutamil transpeptidaz ve alkalen fosfataz değerlerinden biri veya birkaçı yüksek bulundu. Bu vakaların 26'smda (%76,4) steatoz. Tinde (%2,9) siroz, 2'sinde (% 5,8) kronik viral hepatit saptandı. Sonuç: Diabetes Mellituslu hastalarda kan şekeri regülasyonu bozuksa ve hastalık 10 yılını doldurmuşsa karaciğer steatozu ve hepatomegali sıklığı artmaktadır.

🔖

Cite This Article

KAYAÇETİN, E., KISAKOL, G., ÜNLER, K. G. (2022). Diabetes mellitus and liver functions. Endokrinolojide Yönelişler, Cilt: 11 - Sayı: 4, 157–159. https://ajindex.com/articles/500923

References (1)

  1. Isselbacher KJ and Podolsky DK: Infiltrative and Metabolic Diseases affecting the liver, In:Principles of Internal Medicine. Edited by Hari- son TR. New York, 1998, pp: 1717-1720 2. Brent A, Neusch wander T: The liver in systemic Disease, In:Diagno- sis and Treatment in Gastroenterology, Edited by Grendell H, MC Qu- ard KR, Friedman SL. New York, pp: 585-597 3. Weber JR, Ryon Sc: Effects on the gut of systemic disease end other extraintestinal conditions, In: Gastrointestinal and Liver Disease. Edi¬ted by Feldman M, Scharschmidt BF, Sleisenger MH, Philadelphia, Pennysylvania, pp:441-431. 4. Salmela PI, Sataniemi EA, Niemi M, Maentausta O:Liver function tests in diabetic patients. Diabetes Care 7: 248-254,1984. 5. Colloredo Mels G, Bettale G, Bellati G, Guanziroli M, Bertone V, An- geli G. Gamma glutamyl transpeptidaz in diabetics: a case control study. Clin Chim Acta 175:189-195,1988. 6. Araujo LM, De Oliveira DA, Nunes DS. Liver and biliary ultrasonog- raphy in diabetic and non-diabetic obese woman. Diabetes Metab 24:458-462,1998. 7. Türkdoğan MK, Algün E. Diabetes Mellitusta Gastrointestinal ve He- patobiliyer sistem bozuklukları. Tklin Gastroenterohepatoloji 7:60- 65,1996 8. Ersöz G, Özgen G, Aydın A, Erensoy S, Musoğlu A. Diabetes Mellitus- lu Hastalarda Karaciğer Hastalığı 9:22-27. 9. Ertem S, Özütemiz AÖ, Aydın A, Yönetci N, Keskin M, Batur Y. İz¬ mir'de Genel Kadınlarda AntiHCV prevalansı. Gastroenteroloji 4:591- 593,1993. 10. Özenirler S, Kandilci V, Çakir N. Diabetes Mellituslu hastalarda hepa¬ tic C virüs antikoru. XII. Ulusal Gastroenteroloji Kongresi özet bildiri kitabı İzmir:l6l:1995. 11. Efe B, Sarıçam T, Dinçer S, Akalın A, Erenoğlu E. Diabetes Mellituslu hastalarda Hepatit B virüsüne ilişkin serolojik bulgular 2:135-139,1991. 12. Kingston ME, Ali MA, Atiyeh M, Donnely RJ. Diabetes mellitus in chro¬ nic active hepatitis and cirrhosis. Gastroenterology 87:688-694,1984.